United States Paclitaxel Injection Market Report 2016

November 2016 | 108 pages | ID: U7669DE9705EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Paclitaxel Injection

Revenue, means the sales value of Paclitaxel Injection

This report studies sales (consumption) of Paclitaxel Injection in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bristol-Myers Squibb
• Celgene Corporation
• Hospira
• Biological E.
• Taj Accura
• Khandelwal Laboratories
• Luye Pharma
• Beijing Youcare
• Beijing Union
• Haiyao
• Chuntch

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• 30 mg/5 mL
• 60 mg/10 mL
• 100 mg/16.7 mL
• 150 mg/25 mL
• 300 mg/50 mL

Split by applications, this report focuses on sales, market share and growth rate of Paclitaxel Injection in each application, can be divided into

• Ovarian cancer
• Breast cancer
• Cervical cancer
• Pancreatic cancer
• Others

Contents

United States Paclitaxel Injection Market Report 2016

1 PACLITAXEL INJECTION OVERVIEW

1.1 Product Overview and Scope of Paclitaxel Injection
1.2 Classification of Paclitaxel Injection
  1.2.1 30 mg/5 mL
  1.2.2 60 mg/10 mL
  1.2.3 100 mg/16.7 mL
  1.2.4 150 mg/25 mL
  1.2.5 300 mg/50 mL
1.3 Application of Paclitaxel Injection
  1.3.1 Ovarian cancer
  1.3.2 Breast cancer
  1.3.3 Cervical cancer
  1.3.4 Pancreatic cancer
  1.3.5 Others
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Paclitaxel Injection (2011-2021)
  1.4.1 United States Paclitaxel Injection Sales and Growth Rate (2011-2021)
  1.4.2 United States Paclitaxel Injection Revenue and Growth Rate (2011-2021)

2 UNITED STATES PACLITAXEL INJECTION COMPETITION BY MANUFACTURERS

2.1 United States Paclitaxel Injection Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Paclitaxel Injection Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Paclitaxel Injection Average Price by Manufactures (2015 and 2016)
2.4 Paclitaxel Injection Market Competitive Situation and Trends
  2.4.1 Paclitaxel Injection Market Concentration Rate
  2.4.2 Paclitaxel Injection Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PACLITAXEL INJECTION SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Paclitaxel Injection Sales and Market Share by Type (2011-2016)
3.2 United States Paclitaxel Injection Revenue and Market Share by Type (2011-2016)
3.3 United States Paclitaxel Injection Price by Type (2011-2016)
3.4 United States Paclitaxel Injection Sales Growth Rate by Type (2011-2016)

4 UNITED STATES PACLITAXEL INJECTION SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Paclitaxel Injection Sales and Market Share by Application (2011-2016)
4.2 United States Paclitaxel Injection Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES PACLITAXEL INJECTION MANUFACTURERS PROFILES/ANALYSIS

5.1 Bristol-Myers Squibb
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Paclitaxel Injection Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Celgene Corporation
  5.2.2 Paclitaxel Injection Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Celgene Corporation Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Hospira
  5.3.2 Paclitaxel Injection Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Hospira Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Biological E.
  5.4.2 Paclitaxel Injection Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Biological E. Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Taj Accura
  5.5.2 Paclitaxel Injection Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Taj Accura Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Khandelwal Laboratories
  5.6.2 Paclitaxel Injection Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Khandelwal Laboratories Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Luye Pharma
  5.7.2 Paclitaxel Injection Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Luye Pharma Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Beijing Youcare
  5.8.2 Paclitaxel Injection Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Beijing Youcare Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Beijing Union
  5.9.2 Paclitaxel Injection Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Beijing Union Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Haiyao
  5.10.2 Paclitaxel Injection Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Haiyao Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Chuntch

6 PACLITAXEL INJECTION MANUFACTURING COST ANALYSIS

6.1 Paclitaxel Injection Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Paclitaxel Injection

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Paclitaxel Injection Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Paclitaxel Injection Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES PACLITAXEL INJECTION MARKET FORECAST (2016-2021)

10.1 United States Paclitaxel Injection Sales, Revenue Forecast (2016-2021)
10.2 United States Paclitaxel Injection Sales Forecast by Type (2016-2021)
10.3 United States Paclitaxel Injection Sales Forecast by Application (2016-2021)
10.4 Paclitaxel Injection Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Paclitaxel Injection
Table Classification of Paclitaxel Injection
Figure United States Sales Market Share of Paclitaxel Injection by Type in 2015
Figure 30 mg/5 mL Picture
Figure 60 mg/10 mL Picture
Figure 100 mg/16.7 mL Picture
Figure 150 mg/25 mL Picture
Figure 300 mg/50 mL Picture
Table Application of Paclitaxel Injection
Figure United States Sales Market Share of Paclitaxel Injection by Application in 2015
Figure Ovarian cancer Examples
Figure Breast cancer Examples
Figure Cervical cancer Examples
Figure Pancreatic cancer Examples
Figure Others Examples
Figure United States Paclitaxel Injection Sales and Growth Rate (2011-2021)
Figure United States Paclitaxel Injection Revenue and Growth Rate (2011-2021)
Table United States Paclitaxel Injection Sales of Key Manufacturers (2015 and 2016)
Table United States Paclitaxel Injection Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Paclitaxel Injection Sales Share by Manufacturers
Figure 2016 Paclitaxel Injection Sales Share by Manufacturers
Table United States Paclitaxel Injection Revenue by Manufacturers (2015 and 2016)
Table United States Paclitaxel Injection Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Paclitaxel Injection Revenue Share by Manufacturers
Table 2016 United States Paclitaxel Injection Revenue Share by Manufacturers
Table United States Market Paclitaxel Injection Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Paclitaxel Injection Average Price of Key Manufacturers in 2015
Figure Paclitaxel Injection Market Share of Top 3 Manufacturers
Figure Paclitaxel Injection Market Share of Top 5 Manufacturers
Table United States Paclitaxel Injection Sales by Type (2011-2016)
Table United States Paclitaxel Injection Sales Share by Type (2011-2016)
Figure United States Paclitaxel Injection Sales Market Share by Type in 2015
Table United States Paclitaxel Injection Revenue and Market Share by Type (2011-2016)
Table United States Paclitaxel Injection Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Paclitaxel Injection by Type (2011-2016)
Table United States Paclitaxel Injection Price by Type (2011-2016)
Figure United States Paclitaxel Injection Sales Growth Rate by Type (2011-2016)
Table United States Paclitaxel Injection Sales by Application (2011-2016)
Table United States Paclitaxel Injection Sales Market Share by Application (2011-2016)
Figure United States Paclitaxel Injection Sales Market Share by Application in 2015
Table United States Paclitaxel Injection Sales Growth Rate by Application (2011-2016)
Figure United States Paclitaxel Injection Sales Growth Rate by Application (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Paclitaxel Injection Sales Market Share (2011-2016)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Corporation Paclitaxel Injection Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Paclitaxel Injection Sales Market Share (2011-2016)
Table Biological E. Basic Information List
Table Biological E. Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biological E. Paclitaxel Injection Sales Market Share (2011-2016)
Table Taj Accura Basic Information List
Table Taj Accura Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taj Accura Paclitaxel Injection Sales Market Share (2011-2016)
Table Khandelwal Laboratories Basic Information List
Table Khandelwal Laboratories Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Khandelwal Laboratories Paclitaxel Injection Sales Market Share (2011-2016)
Table Luye Pharma Basic Information List
Table Luye Pharma Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Luye Pharma Paclitaxel Injection Sales Market Share (2011-2016)
Table Beijing Youcare Basic Information List
Table Beijing Youcare Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beijing Youcare Paclitaxel Injection Sales Market Share (2011-2016)
Table Beijing Union Basic Information List
Table Beijing Union Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Beijing Union Paclitaxel Injection Sales Market Share (2011-2016)
Table Haiyao Basic Information List
Table Haiyao Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Haiyao Paclitaxel Injection Sales Market Share (2011-2016)
Table Chuntch Basic Information List
Table Chuntch Paclitaxel Injection Sales, Revenue, Price and Gross Margin (2011-2016)
Table Chuntch Paclitaxel Injection Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Paclitaxel Injection
Figure Manufacturing Process Analysis of Paclitaxel Injection
Figure Paclitaxel Injection Industrial Chain Analysis
Table Raw Materials Sources of Paclitaxel Injection Major Manufacturers in 2015
Table Major Buyers of Paclitaxel Injection
Table Distributors/Traders List
Figure United States Paclitaxel Injection Production and Growth Rate Forecast (2016-2021)
Figure United States Paclitaxel Injection Revenue and Growth Rate Forecast (2016-2021)
Table United States Paclitaxel Injection Production Forecast by Type (2016-2021)
Table United States Paclitaxel Injection Consumption Forecast by Application (2016-2021)